A Female Libido Drug Rejected by the FDA Is Being Retested

Published February 14, 2014

A Female Libido Drug Rejected by the FDA Is Being Retested
Two months after the Food and Drug Administration rejected a pill to treat low sexual drive in women, the drug's maker, Sprout Pharmaceuticals, has agreed to conduct additional testing on the product. If approved, flibanserin would be the first drug on …
Read more on Businessweek

Naloxone drug overdose treatment program saves lives
ACT Health agreed to buy the drug for the first 200 participants in the pilot program in late 2011 and early 2012, before it was listed on the Pharmaceutical Benefits Scheme in December 2012. Once the program reaches 200 participants, users will need …
Read more on The Canberra Times

More Drug Treatment News 2011 Information…